Summary
- Current Price
- As of today, CRVS price is $14.27, up +1.64% on
- Current Price All-Time High
- CRVS price is currently -47.05% below its historical high of $26.95 set on
- Market Cap
- CRVS current market cap is $1B, up +180.66% over the past 365 days
- Revenue
- CRVS current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for CRVS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Corvus Pharmaceuticals, Inc. |
| Ticker | NASDAQ: CRVS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | corvuspharma.com |
| Employees | 31 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $14.27 | |
| Price, 1D Change | +1.64% | |
| $1B | ||
| - | ||
| - | ||
| -0.50 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.54 | ||
| EPS, 1Y Change | +47.41% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.54 | ||
| EPS Estimate | -$0.78 | N/A |
| EPS Est. Change | -44.73% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $14.27 | |
| Price Target | $32.00 | - |
| Price Tgt. Change | +124.25% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.92 | -$1.02 | -10.78% | |
| -$0.16 | -$0.54 | -235.75% | |
| -$0.78 | N/A | -44.73% | |
| -$1.07 | N/A | -98.72% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $4.55M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $14.27 | |
| $13.68 | ||
| $14.29 | ||
| $12.90 | ||
| $14.19 | ||
| $0.10 | ||
| -0.50 | ||
| $0.72 | ||
| 49.22 | ||
| 54.43% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$0.54 | ||
| -$105.00K | ||
| - | ||
| -$42.97M | ||
| - | ||
| -$15.28M | ||
| - | ||
| -$42.87M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.02 | ||
| 6.21 | ||
| 6.21 | ||
| - | ||
| - | ||
| 63.36 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 5.33 | ||
| -17.34 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $61.20M | ||
| $56.75M | ||
| $71.12M | ||
| $58.21M | ||
| $9.91M | ||
| $9.38M | ||
| $937.00K | ||
| $403.00K | ||
| $2.49M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $15.28M | ||
| $42.87M | ||
| $105.00K | ||
| $0.00 | ||
| $105.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$32.80M | ||
| -$7.80M | ||
| $36.43M | ||
| $174.00K | ||
| -$32.97M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Goldman Sachs | ||
| Oppenheimer | → | |
| Jefferies | → | |
| Oppenheimer | → | |
| Barclays | → | |
| HC Wainwright & Co. | → | |
| Barclays | ||
| Mizuho | → | |
| Oppenheimer | → | |
| Oppenheimer | → |
Analyst sentiment
Institutional ownership
Screeners with CRVS
FAQ
- What is the ticker symbol for Corvus Pharmaceuticals, Inc.?
- The ticker symbol for Corvus Pharmaceuticals, Inc. is NASDAQ:CRVS
- Does Corvus Pharmaceuticals, Inc. pay dividends?
- No, Corvus Pharmaceuticals, Inc. does not pay dividends
- What sector is Corvus Pharmaceuticals, Inc. in?
- Corvus Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Corvus Pharmaceuticals, Inc. in?
- Corvus Pharmaceuticals, Inc. is in the Biotechnology industry
- What country is Corvus Pharmaceuticals, Inc. based in?
- Corvus Pharmaceuticals, Inc. is headquartered in United States
- When did Corvus Pharmaceuticals, Inc. go public?
- Corvus Pharmaceuticals, Inc. initial public offering (IPO) was on March 23, 2016
- Is Corvus Pharmaceuticals, Inc. in the S&P 500?
- No, Corvus Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Corvus Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Corvus Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Corvus Pharmaceuticals, Inc. in the Dow Jones?
- No, Corvus Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Corvus Pharmaceuticals, Inc. last earnings report?
- Corvus Pharmaceuticals, Inc.'s most recent earnings report was on August 6, 2026
- When does Corvus Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for Corvus Pharmaceuticals, Inc. is November 3, 2026
Data Sources & References
- CRVS Official Website www.corvuspharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1626971/000110465926027047/0001104659-26-027047-index.htm
- CRVS Profile on Yahoo Finance finance.yahoo.com/quote/CRVS
- CRVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/crvs